Published in Curr Opin Microbiol on February 01, 2008
Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci Transl Med (2013) 1.88
Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol (2009) 1.69
Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection. FEMS Microbiol Rev (2012) 1.55
Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun (2009) 1.46
The role of Toll-like receptors in renal diseases. Nat Rev Nephrol (2010) 1.42
The innate immune response during urinary tract infection and pyelonephritis. Pediatr Nephrol (2013) 1.10
TLR-Dependent Human Mucosal Epithelial Cell Responses to Microbial Pathogens. Front Immunol (2014) 0.97
Uropathogenic Escherichia coli Suppresses the host inflammatory response via pathogenicity island genes sisA and sisB. Infect Immun (2009) 0.94
Toll-like receptor 4 and comorbid pain in Interstitial Cystitis/Bladder Pain Syndrome: a multidisciplinary approach to the study of chronic pelvic pain research network study. Brain Behav Immun (2015) 0.91
Toll-like receptors in kidney disease. Curr Opin Nephrol Hypertens (2009) 0.90
Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation. Am J Physiol Renal Physiol (2013) 0.89
Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis. J Infect Dis (2014) 0.87
Association of Toll-like receptor 4 gene polymorphism and expression with urinary tract infection types in adults. PLoS One (2010) 0.85
Toll-like receptors in urothelial cells--targets for cancer immunotherapy. Nat Rev Urol (2013) 0.85
Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr Opin Infect Dis (2015) 0.84
The potential repertoire of the innate immune system in the bladder: expression of pattern recognition receptors in the rat bladder and a rat urothelial cell line (MYP3 cells). Int Urol Nephrol (2015) 0.82
SIGIRR participates in negative regulation of LPS response and tolerance in human bladder epithelial cells. BMC Immunol (2015) 0.77
Regulation of cytotoxic T lymphocyte antigen 4 by cyclic AMP. Am J Respir Cell Mol Biol (2012) 0.76
Sleeping beauty: awakening urothelium from its slumber. Am J Physiol Renal Physiol (2017) 0.75
The role of toll-like receptors (TLRs) in urinary tract infections (UTIs). Cent European J Urol (2016) 0.75
Testosterone suppresses uropathogenic Escherichia coli invasion and colonization within prostate cells and inhibits inflammatory responses through JAK/STAT-1 signaling pathway. PLoS One (2017) 0.75
Pathogen recognition and innate immunity. Cell (2006) 44.14
Intracellular bacterial biofilm-like pods in urinary tract infections. Science (2003) 7.10
Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am (1997) 5.27
A toll-like receptor that prevents infection by uropathogenic bacteria. Science (2004) 5.26
Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A (2004) 4.12
Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A (2006) 3.36
Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A (2000) 2.98
Selective cytokine production by epithelial cells following exposure to Escherichia coli. Infect Immun (1993) 2.83
Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med (2007) 2.72
Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A (2007) 2.56
Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell Microbiol (2007) 2.48
Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection. J Immunol (1987) 2.37
Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun (1984) 2.35
Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J Immunol (2001) 2.27
Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae. Nature (1988) 2.24
Bacterial virulence in urinary tract infection. Infect Dis Clin North Am (1997) 2.20
Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J Cell Sci (2001) 2.13
Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect Immun (2006) 2.11
Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog (2007) 2.01
Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol (2001) 1.81
The uroepithelium: not just a passive barrier. Traffic (2004) 1.75
Bacterial penetration of bladder epithelium through lipid rafts. J Biol Chem (2004) 1.72
Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol (2007) 1.57
Maturation of intracellular Escherichia coli communities requires SurA. Infect Immun (2006) 1.56
Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun (2005) 1.55
Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell Microbiol (2006) 1.53
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa. Infect Immun (2004) 1.48
TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe (2007) 1.47
Microbial entry through caveolae: variations on a theme. Cell Microbiol (2002) 1.44
A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog (2007) 1.41
CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect Immun (2003) 1.38
Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa. Kidney Int (2007) 1.37
Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways. J Immunol (2006) 1.35
Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli. J Bacteriol (2005) 1.35
Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol (2006) 1.32
Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol (2006) 1.32
Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun (2007) 1.29
Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis (2007) 1.26
complex interplay between type 1 fimbrial expression and flagellum-mediated motility of uropathogenic Escherichia coli. J Bacteriol (2007) 1.24
Intracellular trafficking of raft/caveolae domains: insights from integrin signaling. Semin Cell Dev Biol (2007) 1.15
Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis. Cell Microbiol (2007) 0.97
Cytokine repertoire of epithelial cells lining the human urinary tract. J Urol (1998) 0.97
Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Guérin through Toll-like receptor signalling. BJU Int (2006) 0.85
Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med (2007) 2.72
Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol (2003) 2.68
Mast cell activators: a new class of highly effective vaccine adjuvants. Nat Med (2008) 2.27
Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production. Eukaryot Cell (2006) 1.92
Concern c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in mice. Am J Respir Crit Care Med (2011) 1.91
Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity (2013) 1.80
Bacterial penetration of bladder epithelium through lipid rafts. J Biol Chem (2004) 1.72
Cell biology and physiology of the uroepithelium. Am J Physiol Renal Physiol (2009) 1.69
Attenuated virulence of a Francisella mutant lacking the lipid A 4'-phosphatase. Proc Natl Acad Sci U S A (2007) 1.64
TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe (2007) 1.47
Microbial entry through caveolae: variations on a theme. Cell Microbiol (2002) 1.44
Mast cell-derived particles deliver peripheral signals to remote lymph nodes. J Exp Med (2009) 1.42
A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog (2007) 1.41
Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A (2011) 1.40
TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc Natl Acad Sci U S A (2009) 1.38
The role of lipid rafts in the pathogenesis of bacterial infections. Biochim Biophys Acta (2005) 1.23
The distinct binding specificities exhibited by enterobacterial type 1 fimbriae are determined by their fimbrial shafts. J Biol Chem (2005) 1.20
Innate immunity and its regulation by mast cells. J Immunol (2013) 1.19
Mast cell modulation of the vascular and lymphatic endothelium. Blood (2011) 1.19
Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe (2009) 1.17
Pseudomonas invasion of type I pneumocytes is dependent on the expression and phosphorylation of caveolin-2. J Biol Chem (2004) 1.13
Synthetic mast-cell granules as adjuvants to promote and polarize immunity in lymph nodes. Nat Mater (2012) 1.12
Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli. Immunol Lett (2004) 1.10
Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife (2013) 1.10
The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen. Vaccine (2009) 1.09
The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol (2002) 1.06
Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol (2003) 1.04
Counteracting signaling activities in lipid rafts associated with the invasion of lung epithelial cells by Pseudomonas aeruginosa. J Biol Chem (2009) 1.02
Convergent Evolution of Calcineurin Pathway Roles in Thermotolerance and Virulence in Candida glabrata. G3 (Bethesda) (2012) 1.02
Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines. Nat Med (2009) 0.99
Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice. PLoS One (2010) 0.99
Intestinal mast cells mediate gut injury and systemic inflammation in a rat model of deep hypothermic circulatory arrest. Crit Care Med (2013) 0.91
Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits. PLoS One (2011) 0.91
Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activation. J Clin Invest (2011) 0.91
Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis. Nat Rev Microbiol (2013) 0.91
Harboring of particulate allergens within secretory compartments by mast cells following IgE/FcepsilonRI-lipid raft-mediated phagocytosis. J Immunol (2006) 0.89
The mast cell in innate and adaptive immunity. Adv Exp Med Biol (2011) 0.89
Stable dry powder formulation for nasal delivery of anthrax vaccine. J Pharm Sci (2011) 0.86
Surfactant protein D decreases pollen-induced IgE-dependent mast cell degranulation. Am J Physiol Lung Cell Mol Physiol (2005) 0.85
Plasticity in mast cell responses during bacterial infections. Curr Opin Microbiol (2011) 0.85
Involvement of dynamin-2 in formation of discoid vesicles in urinary bladder umbrella cells. Cell Tissue Res (2009) 0.85
New roles for mast cells in modulating allergic reactions and immunity against pathogens. Curr Opin Immunol (2009) 0.83
The expanding roles of caveolin proteins in microbial pathogenesis. Commun Integr Biol (2009) 0.83
Interplay between vesicoureteric reflux and kidney infection in the development of reflux nephropathy in mice. Dis Model Mech (2013) 0.82
New roles for mast cells in pathogen defense and allergic disease. Discov Med (2010) 0.81
A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen. Vaccine (2013) 0.81
In vivo models for studying mast cell-dependent responses to bacterial infection. Methods Mol Biol (2006) 0.78
Complete Genome Sequence of Uropathogenic Escherichia coli Strain CI5. Genome Announc (2015) 0.78
A Mast Cell Degranulation Screening Assay for the Identification of Novel Mast Cell Activating Agents. Medchemcomm (2013) 0.77
Increased Nitric Oxide Production Prevents Airway Hyperresponsiveness in Caveolin-1 Deficient Mice Following Endotoxin Exposure. J Allergy Ther (2012) 0.76
Kidney α-intercalated cells and lipocalin 2: defending the urinary tract. J Clin Invest (2014) 0.76
Mast cell desensitization inhibits calcium flux and aberrantly remodels actin. J Clin Invest (2016) 0.75
How mast cells make decisions. J Clin Invest (2016) 0.75
Mast cell TNF receptors regulate responses to Mycoplasma pneumoniae in surfactant protein A (SP-A)-/- mice. J Allergy Clin Immunol (2012) 0.75
Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activation. J Clin Invest (2017) 0.75